Immutep Ltd
ASX:IMM
Immutep Ltd
ASX:IMM
Price:
0.44 AUD
Market Closed
Updated:
May 30, 2024
Immutep Ltd
Other Operating Expenses
|
Immutep Ltd
Other Operating Expenses Peer Comparison
Comparables:
MSB
CSL
CUV
TLX
PYC
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Immutep Ltd
ASX:IMM
|
Other Operating Expenses
-AU$117.1k
|
CAGR 3-Years
44%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mesoblast Ltd
ASX:MSB
|
Other Operating Expenses
$8.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
106%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Other Operating Expenses
-AU$34.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Immutep Ltd's Other Operating Expenses?
Other Operating Expenses
-117.1k
AUD
-117.1k
AUD
Based on the financial report for Dec 31, 2023, Immutep Ltd's Other Operating Expenses amounts to -117.1k AUD.
What is Immutep Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 3Y
44%
44%
Over the last year, the Other Operating Expenses growth was 47%. The average annual Other Operating Expenses growth rates for Immutep Ltd have been 44% over the past three years .
You don't have any saved screeners yet
